Developmental consequences of antenatal dexamethasone treatment in nonhuman primates.
about
Natural variation in gestational cortisol is associated with patterns of growth in marmoset monkeys (Callithrix geoffroyi)Sex and stress hormone influences on the expression and activity of brain-derived neurotrophic factor.Minireview: the impact of antenatal therapeutic synthetic glucocorticoids on the developing fetal brainApe conservation physiology: fecal glucocorticoid responses in wild Pongo pygmaeus morio following human visitationNeurobehavioral risk is associated with gestational exposure to stress hormones.Nutritionally mediated programming of the developing immune systemChallenges to maternal wellbeing during pregnancy impact temperament, attention, and neuromotor responses in the infant rhesus monkeyThe prolonged effect of repeated maternal glucocorticoid exposure on the maternal and fetal leptin/insulin-like growth factor axis in Papio speciesThe timing of prenatal exposure to maternal cortisol and psychosocial stress is associated with human infant cognitive development.Maternal prenatal cortisol and infant cognitive development: moderation by infant-mother attachment.Prenatal maternal cortisol concentrations predict neurodevelopment in middle childhood.Vital and vulnerable functions of the primate placenta critical for infant health and brain development.Interplay between Depressive-Like Behavior and the Immune System in an Animal Model of Prenatal Dexamethasone AdministrationMimicking maternal smoking and pharmacotherapy of preterm labor: fetal nicotine exposure enhances the effect of late gestational dexamethasone treatment on noradrenergic circuitsGlucocorticoid exposure of sheep at 0.7 to 0.75 gestation augments late-gestation fetal stress responses.Prenatal Programming of Postnatal Susceptibility to Memory Impairments: A Developmental Double Jeopardy.Antenatal dexamethasone treatment leads to changes in gene expression in a murine late placenta.Effects of antenatal corticosteroids on the hypothalamic-pituitary-adrenocortical axis of the fetus and newborn: experimental findings and clinical considerations.Exposure to dexamethasone during late gestation causes female-specific decreases in core body temperature and prepro-thyrotropin-releasing hormone expression in the paraventricular nucleus of the hypothalamus in rats.Repeated courses of antenatal corticosteroids have adverse effects on aspects of brain development in naturally delivered baboon infants.Hormone levels in neonatal hair reflect prior maternal stress exposure during pregnancyFetal glucocorticoid exposure is associated with preadolescent brain development.Antenatal betamethasone treatment has a persisting influence on infant HPA axis regulation.Critical prenatal and postnatal periods for persistent effects of dexamethasone on serotonergic and dopaminergic systems.Adverse neurodevelopmental effects of dexamethasone modeled in PC12 cells: identifying the critical stages and concentration thresholds for the targeting of cell acquisition, differentiation and viability.Identification of glucocorticoid-regulated genes that control cell proliferation during murine respiratory development.Long-lasting effects of dexamethasone on immune cells and wound healing in the zebrafish.
P2860
Q24600598-A51D3613-0872-4633-8CFE-6EBB1F05413AQ26866575-CB61B4A7-9880-44DF-BC17-603A2C884614Q28085262-D6CC5360-F1AC-4D85-A2DC-88F515490530Q28731286-6EBD3903-5562-4E84-B642-C16B541DE0C8Q30461149-BFC919B4-5D45-4B43-98D7-BEF8199744A4Q30463993-69DC8DCC-E544-41D2-A286-431E2EBDD082Q30475625-A5726351-8136-4A3C-B7FC-942C7443C8ABQ33570320-02AC80CF-F6A7-41C8-A876-ABA03E976CEFQ33755588-D5C0D782-A40F-4AC9-BDDC-2D01CE83D4AEQ33858278-BCEBA446-C617-4CA8-8389-B6A27B42839FQ33893835-F9B93393-4AC5-4680-B9FD-4CF6176D3B66Q34244104-1D77FD4C-12D4-43DC-AC47-7B41A3A4716FQ34565661-125FD1F8-7B30-4C84-BD41-D6654B5BF72DQ35552698-B629415E-FCB5-4283-A48E-369195933F6BQ35798962-DE5B35D2-F8EF-4237-BC8A-82AD8D76008EQ35858621-12B1F96C-8024-43FC-A9FB-3D6D8F2369DBQ36088980-3223FAEC-21C7-4A9F-ADD0-727540157150Q36360796-965D915B-261E-4C52-8A82-FAD3627BBF8BQ36442274-91FF2E0F-378D-4750-A7CB-2EA705673991Q36638947-71FB491C-513A-4771-8BD8-A4020465069FQ36678060-DFC73927-4924-4ABD-A788-6B607630DC6AQ37701025-75C46A89-0A94-47C4-926C-92FAF59CCD26Q46110425-ACA5C3FB-D6C2-4907-9E4F-46B39ED2AB26Q46701577-3B7B0FCF-2E01-4136-B7DC-6E71DAFC1185Q47681892-D76FE9C2-A945-4C6F-BD98-518C68D91819Q51976577-EEA6D215-86CE-4CEA-83DA-C5165793C64AQ53360801-13BD274A-936D-4603-8D66-BA8402B5FCC1
P2860
Developmental consequences of antenatal dexamethasone treatment in nonhuman primates.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Developmental consequences of antenatal dexamethasone treatment in nonhuman primates.
@ast
Developmental consequences of antenatal dexamethasone treatment in nonhuman primates.
@en
type
label
Developmental consequences of antenatal dexamethasone treatment in nonhuman primates.
@ast
Developmental consequences of antenatal dexamethasone treatment in nonhuman primates.
@en
prefLabel
Developmental consequences of antenatal dexamethasone treatment in nonhuman primates.
@ast
Developmental consequences of antenatal dexamethasone treatment in nonhuman primates.
@en
P1476
Developmental consequences of antenatal dexamethasone treatment in nonhuman primates.
@en
P2093
Christopher L Coe
Gabriele R Lubach
P304
P356
10.1016/J.NEUBIOREV.2004.10.003
P577
2005-04-01T00:00:00Z